1. Home
  2. FTCI vs NSRX Comparison

FTCI vs NSRX Comparison

Compare FTCI & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FTC Solar Inc.

FTCI

FTC Solar Inc.

HOLD

Current Price

$1.63

Market Cap

31.9M

Sector

Technology

ML Signal

HOLD

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.16

Market Cap

37.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTCI
NSRX
Founded
2017
2019
Country
United States
Israel
Employees
N/A
7
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.9M
37.1M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
FTCI
NSRX
Price
$1.63
$3.16
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$10.20
★ $19.67
AVG Volume (30 Days)
★ 469.8K
20.8K
Earning Date
11-11-2026
08-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $99,687,000.00
N/A
Revenue This Year
$38.06
N/A
Revenue Next Year
$58.28
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 110.51
N/A
52 Week Low
$1.62
$1.98
52 Week High
$12.75
$9.50

Technical Indicators

Market Signals
Indicator
FTCI
NSRX
Relative Strength Index (RSI) 28.40 34.51
Support Level N/A $2.90
Resistance Level $2.86 $3.60
Average True Range (ATR) 0.17 0.23
MACD -0.04 -0.07
Stochastic Oscillator 1.39 10.47

Price Performance

Historical Comparison
FTCI
NSRX

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S.-manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: